
Ute Dugan, MD - Chief Medical Officer - LinkedIn
Chief Medical Officer at Parker Institute for Cancer Immunotherapy · Experience: Parker Institute for Cancer Immunotherapy · Location: United States · 10 connections on LinkedIn. View Ute Dugan,...
- 职位: Chief Medical Officer at Parker …
- 位置: Parker Institute for Cancer Immunotherapy
- 人脉数: 10
Ute Dugan - Chief Medical Officer at Parker Institute for Cancer ...
Ute Dugan, MD, PhD, is Chief Medical Officer at the Parker Institute for Cancer Immunotherapy (PICI). She leads clinical and translational research efforts to overcome immunotherapy resistance and advance novel breakthrough treatment combinations.
Ute Dugan - New York, New York, United States - LinkedIn
Chief Medical Officer, Cancer Immunology, Oncology Research and Development, Global Multi-Stakeholder Collaborations, Cancer Care Capacity Building LMICs · Experience: Parker Institute for Cancer...
- 职位: Chief Medical Officer, Cancer …
- 位置: Parker Institute for Cancer Immunotherapy
- 人脉数: 5
Ute Dugan Joins the Parker Institute for Cancer Immunotherapy …
2021年2月16日 · SAN FRANCISCO – The Parker Institute for Cancer Immunotherapy (PICI) announced today the appointment of Ute Dugan, MD, PhD, as Senior Vice President, Clinical Research. In her new role, Dugan oversees PICI’s clinical development, regulatory affairs and translational medicine efforts, with a focus on overcoming immunotherapy resistance and ...
Ute Dugan - Medtech Alert
2022年8月25日 · Ute Dugan, MD, PhD, is Chief Medical Officer at the Parker Institute for Cancer Immunotherapy (PICI). She leads clinical and translational research efforts to overcome immunotherapy resistance and advance novel breakthrough treatment combinations.
Parker Institute Appoints Ute Dugan as Senior Vice President of ...
2021年4月1日 · Research Institutions. Our academic collaborators’ seminal contributions push the field forward. Directory. Our constellation of renowned thinkers and partners
Dr. Ute Dugan Joins Parker Institute for Cancer Immunotherapy
2021年3月20日 · Mission & Vision. Develop breakthrough immune therapies to turn all cancers into curable diseases faster. Leadership & Staff. The driving force behind PICI’s research and operations
Ute Dugan - Chief Medical Officer - Parker Institute for Cancer ...
View Ute Dugan’s profile on LinkedIn, a professional community of 1 billion members. Chief Medical Officer at Parker Institute for Cancer Immunotherapy · Experience: Parker Institute...
- 职位: Chief Medical Officer at Parker …
- 位置: Parker Institute for Cancer Immunotherapy
Ute Dugan's research works | Bristol-Myers Squibb, New York City …
Ute Dugan's 14 research works with 212 citations and 1,556 reads, including: Optimizing Chemotherapy Dose and Schedule by Norton-Simon Mathematical Modeling
Ute Dugan named SVP of clinical research at Parker Institute …
2021年2月19日 · Ute Dugan was named senior vice president of clinical research at the Parker Institute for Cancer Immunotherapy.